-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

623.O3.6 623. Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological III Clinically Relevant Abstract

Symposia: Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Biological therapies, adult, Lymphomas, non-Hodgkin lymphoma, Non-Biological therapies, Clinical Research, B Cell lymphoma, Combination therapy, drug development, Diseases, indolent lymphoma, Therapies, Lymphoid Malignancies, Monoclonal Antibody Therapy, Human
Saturday, December 10, 2022: 2:00 PM-3:30 PM
New Orleans Theater C (Ernest N. Morial Convention Center)
Moderators:
Efstathios Kastritis, MD, and Timothy S. Fenske, MD, Medical College of Wisconsin
Disclosures:
No relevant conflicts of interest to declare.
This session focuses on the studies in Marginal zone lymphoma and Waldenstrom's Macroglobulinemia
2:00 PM

M.Lia Palomba, MD1, Manish R. Patel, MD2, Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD3*, Wojciech Jurczak4, David John Lewis, MBChB, PhD5*, Thomas Gastinne, MD6*, Shuo Ma, MD7, Jonathon B. Cohen, MD, MS8, Krish Patel, MD9, Jennifer R. Brown, MD, PhD10, Lydia Scarfo, MD11*, Talha Munir, MBBS, MRCP, FRCPath, PhD12*, Ewa Lech-Marańda, MD, PhD13*, Marc Hoffmann, MD14, Chaitra S. Ujjani, MD15, Bita Fakhri, MD, MPH16, Michael L. Wang, MD17, Koji Izutsu18*, Hirokazu Nagai, MD, PhD19, Constantine S. Tam20*, John F. Seymour, MBBS, PhD, FRACP20, Joanna M. Rhodes, MD, MSCE21, Julie M. Vose, MD, MBA22, Matthew McKinney, MD23*, James N. Gerson, MD24, Minal A. Barve, MD25*, Bryone J. Kuss, MBBS, PhD, FRACP, FRCPA, Fsc26, Youngil Koh, MD, PhD27, Wei Gao, MS28*, Amy S. Ruppert, PhD28*, Richard A. Walgren, MD, PhD29, Donald E. Tsai, MD, PhD29*, Binoj Nair, PhD29*, Katherine Bao, PhD29*, Anthony R. Mato, MD, MSCE1 and Chan Yoon Y. Cheah, MD30

1Memorial Sloan Kettering Cancer Center, New York, NY
2Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, FL
3Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, United Kingdom
4Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
5Plymouth Hospitals NHS Trust - Derriford Hospital, Plymouth, United Kingdom
6Centre Hospitalier Universitaire de Nantes, Nantes, France
7Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL
8Winship Cancer Institute, Emory University, Atlanta, GA
9Swedish Cancer Institute, Seattle, WA
10Dana-Farber Cancer Institute and Harvard Medical School, Boston
11Università Vita-salute San Raffaele and IRCC Ospedale San Raffaele, Milan, Italy
12Department of Haematology, St. James's University Hospital, Leeds, United Kingdom
13Institute of Hematology and Transfusion Medicine, Warsaw, Poland
14The University of Kansas Cancer Center, Kansas City, KS
15Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
16University of California San Francisco Medical Center, San Francisco, CA
17University of Texas, MD Anderson Cancer Center, Houston, TX
18National Cancer Center Hospital, Tokyo, Japan
19National Hospital Organization Nagoya Medical Center, Nagoya, Japan
20Peter MacCallum Cancer Centre, Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC, Australia
21Northwell Health Cancer Institute, New Hyde Park, NY
22University of Nebraska Medical Center, Omaha, NE
23Duke Cancer Institute, Durham, NC
24Lymphoma Program, Abramson Cancer Center, Philadelphia, PA
25Mary Crowley Cancer Research Center, Dallas, TX
26Flinders University Medical Centre, Bedford Park, Australia
27Seoul National University Hospital, Seoul, Korea, Republic of (South)
28Eli Lilly and Company, Indianapolis, IN
29Loxo@Lilly, Indianapolis, IN
30Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, WEA, Australia

2:15 PM

John P. Leonard, MD1, Marek Trneny, MD2, Fritz Offner, MD, PhD3, Jiri Mayer, Prof, MD4*, Huilai Zhang5*, Grzegorz S. Nowakowski, MD6, Phillip Scheinberg, MD7, Argyrios Gkasiamis, MD8, Joanna Mikita-Geoffroy, PhD9*, Everton Rowe, PhD8* and John G. Gribben, MD, DSc, FRCPath10

1Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY
2Charles University, General Hospital, Prague, Czech Republic
3Ghent University Hospital, Gent, Belgium
4Masaryk University, Brno, Czech Republic
5Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
6Mayo Clinic, Rochester, MN
7Hospital A Beneficênica Portuguesa de São Paulo, Sao Paulo, SP, Brazil
8Bristol Myers Squibb, Princeton, NJ
9Bristol-Myers Squibb Company, Princeton, NJ
10Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

2:30 PM

Jorge J. Castillo, MD1, Shayna Sarosiek, MD2, Andrew R. Branagan, MD3, David J. Sermer, MD4, Catherine A. Flynn, NP2*, Carly Leventoff5*, Megan Little5*, Timothy P White5*, Kirsten Meid, MPH2*, Alexa Canning2*, Maria Luisa Guerrera, MD2, Amanda Kofides2*, Xia Liu, MD2*, Manit Munshi, MS5*, Nicholas Tsakmaklis2*, Christopher J Patterson, MS, MPH5*, Zachary R Hunter, PhD2 and Steven P Treon, MD, PhD2

1Dana Farber Cancer Institute, Boston, MA
2Dana-Farber Cancer Institute, Boston, MA
3Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA
4Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
5Bing Center for Waldenstrom's macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA

2:45 PM

Hun Ju Lee, MD1, Michael Y. Choi, MD2, Tanya Siddiqi, MD3, Joanna M. Rhodes, MD, MSCE4, William G. Wierda, MD, PhD5, Iris Isufi, MD6, Joseph M Tuscano, MD7, Nicole Lamanna, MD8, Suki Subbiah, MD9, Jean L. Koff, MD, MSc10, Lori Leslie, MD11, Alec Goldenberg, MD12*, Gina G Chung, MD13*, James B. Breitmeyer, MD, PhD14, Salim Yazji, MD14, Michael Wang, MD1,15, Catriona Jamieson, MD, PhD16 and Thomas J. Kipps, MD, PhD17

1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
2University of California San Diego, La Jolla, CA
3Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
4Northwell Health Cancer Institute, New Hyde Park, NY
5The University of Texas M.D. Anderson Cancer Center, Houston, TX
6Hematology, Yale University School of Medicine, New Haven, CT
7UC Davis Comprehensive Cancer Center, Sacramento, CA
8Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
9LSU Health Sciences Center, New Orleans, LA
10Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
11Hackensack Meridian School of Medicine, Hackensack, NJ
12Manhattan Hem Onc Associates, New York, NY
13The Christ Hospital, Lindner Center for Research and Education, Cincinnati, OH
14Oncternal Therapeutics, Inc., San Diego, CA
15University of Texas, MD Anderson Cancer Center, Houston, TX
16Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center and Sanford Stem Cell Clinical Center, University of California, San Diego, La Jolla, CA
17Moores Cancer Center, University of California, San Diego, La Jolla, CA

3:00 PM

Catherine Thieblemont, MD, PhD1, Javier Munoz2*, Alessandra Tucci, MD3*, Carlo Visco, MD4*, Guillaume Cartron, MD, PhD5*, Paolo Corradini6, Ian W. Flinn, MD PhD7, Thomas Gastinne, MD8*, Kamal Krimo Bouabdallah,9*, Luca Arcaini10*, Grzegorz S. Nowakowski, MD11, Louise Roulin12*, Max Topp13*, Shekeab Jauhari, MD14*, Vladan Vucinic, MD15*, Peter Martin, FRCPC, MD, MS16, Argyrios Gkasiamis, MD17, James Drew18*, Parth Rao18*, Mark Kaplan18*, Yiming Cheng18*, Ju Li, PhD18* and Franck Morschhauser, MD, PhD19*

1Hôpital Saint-Louis, Paris, France
2Mayo Clinic, Phoenix, AZ
3Spedali Civili di Brescia, Brescia, Italy
4University of Verona, Verona, Italy
5CHU de Montpellier – Hôpital Saint-Eloi, Montpellier, France
6Istituto Nazionale dei Tumori, Milan, Italy
7Sarah Cannon Research Institute, Nashville, TN
8Centre Hospitalier Universitaire de Nantes, Nantes, France
9Hôpital Haut Leveque, Gironde, France
10Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy
11Mayo Clinic, Rochester, MN
12Hôpital Henri Mondor, Creteil, France
13Universitӓtsklinikum Würzburg, Würzburg, Germany
14Florida Cancer Specialists and Research Institute, Sarah Cannon Research Institute, Lake Mary, FL
15Universitӓtsklinikum Leipzig, Leipzig, Germany
16Weill Cornell Medicine, New York, NY
17Bristol Myers Squibb, Boudry, Switzerland
18Bristol Myers Squibb, Princeton, NJ
19Centre Hospitalier Régional Universitaire de Lille, Lille, France

3:15 PM

Stephen Opat1, Alessandra Tedeschi2*, Bei Hu, MD3, Kim M. Linton4*, Pamela McKay, MD5*, Henry Chan6, Jie Jin, PhD7, Mingyuan Sun8*, Magdalena Sobieraj-Teague, MBBS, FRACP, FRCPA, M.Sc9*, Pier Luigi Zinzani, MD, PhD10, Peter J. Browett11, Xiaoyan Ke12*, Craig A. Portell, MD13, Catherine Thieblemont, MD, PhD14, Kirit Ardeshna15*, Fontanet Bijou, MD16*, Patricia Walker, MBBS, BMedSci, FRACP, FRCPA17*, Eliza Hawkes18*, Shir-Jing Ho, MBBS, FRACP, FRCPA, MClinTrial Res19*, Keshu Zhou20*, Zhiyu Liang21*, Jianfeng Xu21*, Chris Tankersley21*, Richard Delarue21*, Melannie Co, MD21* and Judith Trotman, MBChB, FRACP, FRCPA22*

1Monash Health and Monash University, Clayton, Victoria, Australia
2ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
3Levine Cancer Institute/Atrium Health, Charlotte, NC
4Division of Cancer Sciences, Manchester Cancer Research Centre, Manchester, United Kingdom
5Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
6North Shore Hospital, Auckland, New Zealand
7The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China
8Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
9Flinders Medical Centre, Bedford Park, SA, Australia
10Institute of Hematology “Seràgnoli” University of Bologna, Bologna, Italy
11Auckland City Hospital, Grafton, New Zealand
12Peking University Third Hospital, Beijing, China
13Comprehensive Cancer Center, University of Virginia, Charlottesville, VA
14Hemato-oncology, Paris University Diderot, APHP, Hôpital Saint-Louis, Paris, France
15University College London Hospitals, London, United Kingdom
16Institut Bergonié, Bordeaux Cedex, France
17Peninsula Private Hospital, Frankston, VIC, Australia
18Box Hill Hospital, Box Hill, VIC, Australia
19St. George Hospital, Kogarah, NSW, Australia
20Henan Cancer Hospital, Zhengzhou, Henan, China
21BeiGene (Beijing) Co., Ltd., Beijing, China, BeiGene Switzerland GmbH and BeiGene USA, Inc., San Mateo, CA
22University of Sydney, Concord Repatriation General Hospital, Concord, NSW, Australia

*signifies non-member of ASH